Sergiusz Markowicz

Prof. Sergiusz Markowicz


Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1990 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SMSergiusz Markowicz
Sergiusz Markowicz
EEE G Engleman
E G Engleman
Interest in human dendritic cells (DC) has been heightened recently by the discovery that this cell type is a primary target of the human immunodeficiency virus, the causative agent of AIDS. DC are bone marrow-derived cells with an extraordinarily potent ability to promote the immunological activity of T lymphocytes. Unfortunately, since DC constitute less than 0.5% of peripheral blood mononuclear cells and die within a few days of their isolation, they are not readily accessible to study. We report here that granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine with well-recognized effects on granulocyte and macrophage maturation, profoundly affects the morphology and viability of DC isolated from peripheral blood. GM-CSF not only promotes DC survival but also induces DC differentiation to mobile, reversibly adherent cells with long-branched projections. DC cultured in GM-CSF survive for up to 6 wk and retain their ability to stimulate the proliferation of T cells in allogeneic and autologous mixed leukocyte reactions.

1 May 1995 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AMAnita Mehta‐Damani
Anita Mehta‐Damani
SMSergiusz Markowicz
Sergiusz Markowicz
EEEdgar G. Engleman
Edgar G. Engleman

11 February 2016 in Blood
Verified
Journal Article
Closed access
PDF file
MSMaciej Szydlowski
Maciej Szydlowski
PKPrzemyslaw Kiliszek
Przemyslaw Kiliszek
TSTomasz Sewastianik
Tomasz Sewastianik
EJEwa Jablonska
Ewa Jablonska
EBEmilia Białopiotrowicz
Emilia Białopiotrowicz
PJPrzemysław Juszczyński
Przemysław Juszczyński
Key Points: In tonic BCR signal-dependent DLBCLs, FOXO1 is required for SYK and AKT inhibitor-induced toxicity.

2 May 2016 in Oncogene
Verified
Journal Article
Closed access
TST Sewastianik
T Sewastianik
MSMaciej Szydlowski
Maciej Szydlowski
EJE Jablonska
E Jablonska
EBEmilia Białopiotrowicz
Emilia Białopiotrowicz
PKP Kiliszek
P Kiliszek
PJPrzemysław Juszczyński
Przemysław Juszczyński

1 November 2006 in European Journal of Cancer
Verified
Journal Article
Closed access
MKMagdalena Kowalewska
Magdalena Kowalewska
MCMagdalena Chechlinska
Magdalena Chechlinska
SMSergiusz Markowicz
Sergiusz Markowicz
PKPaulina Kober
Paulina Kober
RNRadosława Nowak
Radosława Nowak

1 November 2011 in Journal of Proteomics
Verified
Journal Article
Closed access
MAMonika Julita Adamczyk-Popławska
Monika Julita Adamczyk-Popławska
SMSergiusz Markowicz
Sergiusz Markowicz
EJElżbieta Jagusztyn-Krynicka
Elżbieta Jagusztyn-Krynicka